“Bupropion and Naltrexone in Methamphetamine Use Disorder.”, N Engl J Med, vol. 384, no. 2, pp. 140-153, 2021.
, “Impact of Personal Protective Equipment on Pediatric Cardiopulmonary Resuscitation Performance: A Controlled Trial.”, Pediatr Emerg Care, vol. 36, no. 6, pp. 267-273, 2020.
, “Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Tasks.”, Pediatr Emerg Care, 2020.
, “Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Procedures by Prehospital Providers.”, Disaster Med Public Health Prep, pp. 1-8, 2020.
, ,
“DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.”, Drug Alcohol Depend, vol. 179, pp. 42-46, 2017.
, “Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.”, J Gen Intern Med, vol. 32, no. 9, pp. 990-996, 2017.
, “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.”, Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
, “Hair analysis and its concordance with self-report for drug users presenting in emergency department.”, Drug Alcohol Depend, vol. 167, pp. 149-55, 2016.
, “Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients.”, Ann Intern Med, vol. 165, no. 10, pp. 690-699, 2016.
, “Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.”, J Addict Med, vol. 10, no. 4, pp. 236-43, 2016.
, “Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.”, Contemp Clin Trials, vol. 39, no. 2, pp. 211-23, 2014.
, “Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.”, JAMA Intern Med, vol. 174, no. 11, pp. 1736-45, 2014.
, “Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.”, J Clin Psychiatry, vol. 75, no. 7, pp. 757-64, 2014.
, “Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.”, Contemp Clin Trials, vol. 33, no. 1, pp. 197-205, 2012.
, “Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.”, Contemp Clin Trials, vol. 33, no. 5, pp. 993-1002, 2012.
,